REFLOTRON CREATINE KINASE TEST TABS— 510(k) K904102
Substantially EquivalentBoehringer Mannheim Corp.
FDA 510(k) clearance K904102 for REFLOTRON CREATINE KINASE TEST TABS, Substantially Equivalent on 1990-09-27. Applicant: Boehringer Mannheim Corp..
Clearance details
- Applicant
- Boehringer Mannheim Corp.
- Product code
- Code CGS
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Indianapolis, IN, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.